Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-25

Clinical Trial Update: Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO

View source ↗

Summary

A completed DISQUO study update describing how symptoms impact quality of life for people with hereditary hemorrhagic telangiectasia (HHT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hereditary Hemorrhagic Telangiectasia (HHT) | Status: COMPLETED